U.S. Markets close in 1 hr 20 mins

Catalyst Pharmaceuticals settles patent dispute with Northwestern University

Emon Reiser
Catalyst Pharmaceuticals settles patent dispute with Northwestern University

Catalyst Pharmaceuticals has ended a legal fight with Northwestern University, according to a recent filing with the U.S. Securities and Exchange Commission. The settlement resolves a patent dispute in which neither company admitted fault, according to Catalyst. The dispute arose from a Aug. 27, 2009, license agreement in which Catalyst tapped Northwestern to develop CPP-115, a drug intended to treat infantile spasms.